PT1838315E - 4-feniltetra-hidro-isoquinolinas substituídas, processo para a sua preparação, a sua utilização como medicamento, bem como medicamento que as contém - Google Patents
4-feniltetra-hidro-isoquinolinas substituídas, processo para a sua preparação, a sua utilização como medicamento, bem como medicamento que as contém Download PDFInfo
- Publication number
- PT1838315E PT1838315E PT58235730T PT05823573T PT1838315E PT 1838315 E PT1838315 E PT 1838315E PT 58235730 T PT58235730 T PT 58235730T PT 05823573 T PT05823573 T PT 05823573T PT 1838315 E PT1838315 E PT 1838315E
- Authority
- PT
- Portugal
- Prior art keywords
- drug
- phenyltetrahydroisoquinolines
- substituted
- producing
- methods
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
- A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
- C07D217/18—Aralkyl radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Obesity (AREA)
- Psychiatry (AREA)
- Endocrinology (AREA)
- Vascular Medicine (AREA)
- Emergency Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Transplantation (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102005001411A DE102005001411A1 (de) | 2005-01-12 | 2005-01-12 | Substituierte 4-Phenyltetrahydroisochinoline, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament, sowie sie enthaltendes Medikament |
Publications (1)
Publication Number | Publication Date |
---|---|
PT1838315E true PT1838315E (pt) | 2014-05-26 |
Family
ID=36121409
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT58235730T PT1838315E (pt) | 2005-01-12 | 2005-12-30 | 4-feniltetra-hidro-isoquinolinas substituídas, processo para a sua preparação, a sua utilização como medicamento, bem como medicamento que as contém |
Country Status (31)
Country | Link |
---|---|
US (1) | US7868003B2 (pt) |
EP (1) | EP1838315B1 (pt) |
JP (1) | JP2008526906A (pt) |
KR (1) | KR20070094916A (pt) |
CN (1) | CN101184488A (pt) |
AR (1) | AR053326A1 (pt) |
AU (1) | AU2005324833A1 (pt) |
BR (1) | BRPI0519854A2 (pt) |
CA (1) | CA2594419A1 (pt) |
CR (1) | CR9191A (pt) |
DE (1) | DE102005001411A1 (pt) |
DK (1) | DK1838315T3 (pt) |
DO (1) | DOP2006000011A (pt) |
ES (1) | ES2470980T3 (pt) |
GT (1) | GT200600017A (pt) |
IL (1) | IL184314A0 (pt) |
MA (1) | MA29227B1 (pt) |
MX (1) | MX2007008269A (pt) |
MY (1) | MY142493A (pt) |
NI (1) | NI200700162A (pt) |
NO (1) | NO20074084L (pt) |
NZ (1) | NZ556080A (pt) |
PA (1) | PA8659501A1 (pt) |
PT (1) | PT1838315E (pt) |
RU (1) | RU2398766C2 (pt) |
TN (1) | TNSN07263A1 (pt) |
TW (1) | TW200637842A (pt) |
UA (1) | UA88941C2 (pt) |
UY (1) | UY29333A1 (pt) |
WO (1) | WO2006074813A1 (pt) |
ZA (1) | ZA200704728B (pt) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2342178B1 (en) | 2008-09-02 | 2016-09-28 | Sanofi | Substituted aminoindanes and analogs thereof, and the pharmaceutical use thereof |
LT2384318T (lt) | 2008-12-31 | 2018-02-26 | Ardelyx, Inc. | Junginiai ir būdai, skirti nhe-medijuoto antiporto slopinimui, gydant sutrikimus, susijusius su skysčių kaupimusi ir druskų pertekliumi, bei virškinamojo trakto sutrikimus |
US10543207B2 (en) | 2008-12-31 | 2020-01-28 | Ardelyx, Inc. | Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders |
US20120088737A2 (en) * | 2009-10-02 | 2012-04-12 | Ajinomoto Co., Inc | Novel acyl guanidine derivatives |
WO2011069951A1 (en) | 2009-12-11 | 2011-06-16 | Glaxo Group Limited | Imidazolidinedione derivatives |
US20130011480A1 (en) * | 2011-05-05 | 2013-01-10 | Rosenberg Mark A | Cytotoxic therapy by proton flux modulation |
MX2015014351A (es) | 2013-04-12 | 2016-04-20 | Ardelyx Inc | Compuestos de union a nhe3 (intercambiador de sodio-hidrogeno 3) y metodos para inhibir transporte de fosfato. |
AU2015293134B2 (en) * | 2014-07-25 | 2019-01-24 | Taisho Pharmaceutical Co., Ltd. | Phenyl tetrahydroisoquinoline compound substituted with heteroaryl |
JP6903923B2 (ja) * | 2016-01-22 | 2021-07-14 | 大正製薬株式会社 | ヘテロアリールで置換されたフェニルテトラヒドロイソキノリン化合物を有効成分として含有する医薬 |
AU2018205400B2 (en) | 2017-01-09 | 2022-07-14 | Ardelyx, Inc. | Compounds useful for treating gastrointestinal tract disorders |
CN110291082A (zh) | 2017-01-09 | 2019-09-27 | 阿德利克斯股份有限公司 | Nhe介导的反向转运的抑制剂 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19633966A1 (de) | 1996-08-22 | 1998-02-26 | Hoechst Ag | Phenylsubstituierte Alkenylcarbonsäure-guanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
DE19945302A1 (de) | 1999-09-22 | 2001-03-29 | Merck Patent Gmbh | Biphenylderivate als NHE-3-Inhibitoren |
AU784280B2 (en) | 1999-11-03 | 2006-03-02 | Albany Molecular Research, Inc. | 4-phenyl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin |
DE19960204A1 (de) | 1999-12-14 | 2001-06-28 | Aventis Pharma Gmbh | Substituierte Norlbornylamino-Derivate, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
DE10015248A1 (de) | 2000-03-28 | 2001-10-04 | Merck Patent Gmbh | Bisamidino-Verbindungen als NHE-3 Inhibitoren |
DE10019062A1 (de) | 2000-04-18 | 2001-10-25 | Merck Patent Gmbh | 2-Guanidino-4-aryl-chinazoline als NHE-3 Inhibitoren |
AU2002356689B2 (en) * | 2001-12-05 | 2008-05-15 | Sanofi-Aventis Deutschland Gmbh | Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, the use thereof as medicaments, in addition to a medicament containing same |
DE10163914A1 (de) | 2001-12-22 | 2003-07-03 | Aventis Pharma Gmbh | Substituierte 4-Phenyltetrahydroisochinolinium-Salze, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament, sowie sie enthaltendes Medikament |
DE10312963A1 (de) * | 2003-03-24 | 2004-10-07 | Aventis Pharma Deutschland Gmbh | Substituierte 4-Phenyltetrahydroisochinoline, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament, sowie sie enthaltendes Medikament |
-
2005
- 2005-01-12 DE DE102005001411A patent/DE102005001411A1/de not_active Withdrawn
- 2005-12-30 CA CA002594419A patent/CA2594419A1/en not_active Abandoned
- 2005-12-30 JP JP2007550712A patent/JP2008526906A/ja not_active Abandoned
- 2005-12-30 NZ NZ556080A patent/NZ556080A/en not_active IP Right Cessation
- 2005-12-30 DK DK05823573.0T patent/DK1838315T3/da active
- 2005-12-30 EP EP05823573.0A patent/EP1838315B1/de active Active
- 2005-12-30 RU RU2007130706/04A patent/RU2398766C2/ru not_active IP Right Cessation
- 2005-12-30 PT PT58235730T patent/PT1838315E/pt unknown
- 2005-12-30 WO PCT/EP2005/014127 patent/WO2006074813A1/de active Application Filing
- 2005-12-30 BR BRPI0519854-2A patent/BRPI0519854A2/pt not_active IP Right Cessation
- 2005-12-30 AU AU2005324833A patent/AU2005324833A1/en not_active Abandoned
- 2005-12-30 ES ES05823573.0T patent/ES2470980T3/es active Active
- 2005-12-30 UA UAA200709180A patent/UA88941C2/ru unknown
- 2005-12-30 CN CNA2005800465296A patent/CN101184488A/zh active Pending
- 2005-12-30 MX MX2007008269A patent/MX2007008269A/es active IP Right Grant
- 2005-12-30 KR KR1020077015974A patent/KR20070094916A/ko not_active Application Discontinuation
-
2006
- 2006-01-10 AR ARP060100092A patent/AR053326A1/es not_active Application Discontinuation
- 2006-01-10 TW TW095100824A patent/TW200637842A/zh unknown
- 2006-01-11 PA PA20068659501A patent/PA8659501A1/es unknown
- 2006-01-11 GT GT200600017A patent/GT200600017A/es unknown
- 2006-01-11 MY MYPI20060103A patent/MY142493A/en unknown
- 2006-01-12 UY UY29333A patent/UY29333A1/es unknown
- 2006-01-12 DO DO2006000011A patent/DOP2006000011A/es unknown
-
2007
- 2007-06-14 ZA ZA200704728A patent/ZA200704728B/en unknown
- 2007-06-19 CR CR9191A patent/CR9191A/es not_active Application Discontinuation
- 2007-06-21 NI NI200700162A patent/NI200700162A/es unknown
- 2007-07-01 IL IL184314A patent/IL184314A0/en unknown
- 2007-07-06 MA MA30050A patent/MA29227B1/fr unknown
- 2007-07-11 US US11/776,041 patent/US7868003B2/en not_active Expired - Fee Related
- 2007-07-11 TN TNP2007000263A patent/TNSN07263A1/en unknown
- 2007-08-07 NO NO20074084A patent/NO20074084L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2006074813A1 (de) | 2006-07-20 |
NI200700162A (es) | 2008-04-21 |
TW200637842A (en) | 2006-11-01 |
NZ556080A (en) | 2009-08-28 |
US20080058328A1 (en) | 2008-03-06 |
CA2594419A1 (en) | 2006-07-20 |
UA88941C2 (ru) | 2009-12-10 |
ZA200704728B (en) | 2008-07-30 |
EP1838315B1 (de) | 2014-03-12 |
EP1838315A1 (de) | 2007-10-03 |
US7868003B2 (en) | 2011-01-11 |
TNSN07263A1 (en) | 2008-12-31 |
NO20074084L (no) | 2007-09-28 |
UY29333A1 (es) | 2006-08-31 |
RU2398766C2 (ru) | 2010-09-10 |
MY142493A (en) | 2010-11-30 |
PA8659501A1 (es) | 2006-09-08 |
DE102005001411A1 (de) | 2006-07-27 |
DK1838315T3 (da) | 2014-06-16 |
CR9191A (es) | 2007-10-04 |
RU2007130706A (ru) | 2009-02-20 |
MA29227B1 (fr) | 2008-02-01 |
CN101184488A (zh) | 2008-05-21 |
JP2008526906A (ja) | 2008-07-24 |
BRPI0519854A2 (pt) | 2009-03-24 |
AU2005324833A1 (en) | 2006-07-20 |
ES2470980T3 (es) | 2014-06-24 |
KR20070094916A (ko) | 2007-09-27 |
IL184314A0 (en) | 2007-10-31 |
GT200600017A (es) | 2006-08-28 |
AR053326A1 (es) | 2007-05-02 |
MX2007008269A (es) | 2008-01-16 |
DOP2006000011A (es) | 2006-07-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1124321A1 (en) | Substituted 4-phenyltetrahydroisoquinolines, method of producing them, their use as medicament, and also medicament containing them | |
IL186523A0 (en) | Substituted pyrrolo-pyridines, composition containing them, method for their producing and use thereof | |
IL184314A0 (en) | Substituted 4-phenyltetrahydroisoquinolines, methods for producing them, their use as drug, and drug containing them | |
HUS1400056I1 (hu) | Glükopiranozil-helyettesített benzol-származékok, az említett vegyületeket tartalmazó gyógyszerek, azok alkalmazása, és eljárás elõállításukra | |
IL184175A (en) | Sulfonyl pyrrolidines, method for producing the same and their use as drugs | |
IL184524A0 (en) | Substituted pyrazolo-pyridines, compositions containing them, method for the production thereof, and their use | |
IL181012A0 (en) | Substituted 8-aminoalkoxi-xanthines, method for the production thereof and use thereof as medicaments | |
IL180874A0 (en) | Substituted, bicyclic 8-pyrrolidinoxanthines, method for the production thereof and their use as medicaments | |
SI1928882T1 (sl) | (s)-n-metilnaltrekson, postopek za njega sintezo in njega farmacevtska uporaba | |
IL185804A0 (en) | Aminocarbonyl-substituted 8-n-benzimidazoles, method for their production and their use as medicaments | |
IL195245A0 (en) | Substituted prolinamides, production thereof and their use as drugs | |
IL191655A0 (en) | Novel compounds, their preparation and use | |
IL179170A0 (en) | Novel substituted thiophenecarboxamides, their production and their use as medicaments | |
IL193339A0 (en) | Novel aminoalcohol-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments | |
IL193341A0 (en) | Novel azacyclyl-substituted arylthienopyrimidinones, process for their preparation and their use as medicaments | |
IL178887A0 (en) | Novel beta agonists, method for producing the same and their use as drugs | |
SI2020410T1 (sl) | Derivati pirido(2,3-d)pirimidina, njihova priprava, njihova terapevtska uporaba | |
IL190596A0 (en) | 9-chloro-15-deoxyprostaglandin derivatives, process for their preparation and their use as medicaments | |
ZA200803116B (en) | Novel indole-containing beta agonists, method for producing them and their use as drugs | |
IL186851A0 (en) | Styrylsulfonamides, their manufacture and use as pharmaceutical agents | |
PL1999112T3 (pl) | Podstawione 2-amino-4-fenylo-dihydrochinoliny, sposób ich wytwarzania, ich zastosowanie jako leku i lek je zawierający | |
IL187419A0 (en) | Heteroarylethenyl derivatives, their manufacture and use as pharmaceutical agents | |
ZA200608023B (en) | Novel substituted thiophenecarboxamides, their production and their use as medicaments | |
ZA200805284B (en) | Tetrafluorotoluene compound, method for producing same and use thereof | |
IL183438A0 (en) | Substituted indoles, compositions containing them, method for the production thereof and their use |